Literature DB >> 18065179

[Assessing the application of Rwanda's national protocol for uncomplicated malaria treatment in healthcare institutions in Kigali City, Rwanda].

M Nzayirambaho1, R J Freund, P Millet, P Lombrail, D Malvy, G Potel.   

Abstract

UNLABELLED: In November 2001, the National Health Ministry of Rwanda advocated a new therapeutic protocol replacing chloroquine by an amodiaquine+sulfadoxine-pyrimethamine combination for the treatment of uncomplicated malaria.
OBJECTIVES: This study had for aim to assess the application of this new protocol in Kigali healthcare institutions. POPULATION AND METHODS: A knowledge, attitudes and practices study (KAP) was carried out between June and August 2003. A questionnaire was answered by 120 care providers working in 15 healthcare institutions selected randomly in health facilities treating uncomplicated malaria. Antimalarial treatments prescribed to 150 patients were also reviewed from consultation files and analyzed.
RESULTS: After analysis, 63.3% prescriptions were in line with the national protocol. Factors associated to the nonobservance of the national protocol were: the carer's ignorance of any recommended treatment, his doubt of efficacy of recommended drugs, and his fear of adverse effects.
CONCLUSIONS: The authors recommend informing the care providers about the national protocol. Findings also demonstrate the need to include care providers in any modifications of the national policy in terms of drug efficacy and potential adverse effects of the new strategy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18065179     DOI: 10.1016/j.medmal.2007.08.003

Source DB:  PubMed          Journal:  Med Mal Infect        ISSN: 0399-077X            Impact factor:   2.152


  1 in total

1.  Healthcare Professional Preferences for Prescribing Artemisinins and Quinine for Malaria in Burundi.

Authors:  Aîné-Ernest Niyonkuru; Eric McLaughlin; Gregory Heath; Sonia Inamuco; Hillary Topazian; Mike Davis
Journal:  East Afr Health Res J       Date:  2021-11-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.